Immunostaining showed that CXCL5 was preferentially expressed in the CAF-rich stromal compartment of the tumor, with vimentin displaying an overlapping pattern of expression with the stroma (Fig. 6E, F and Supplementary Fig. 11). The gene discussed is CXCL5; the disease is neoplasm.